Explore more publications!

Healthcare Wire Texas: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Wire Texas.

Press releases published on October 21, 2025

Onpoint Launches Practice Management as a Service (PMaaS™), Enhances Leadership Team
New Scholarly Articles Spotlight AI’s Promise and the Future of EHR Interoperability
Nobis Rehabilitation Partners Announces Top Performers at Annual CEO Conference
Biomea Fusion to Participate in Citi's SMID Biotech C-Suite Fireside Chat Series
La Asociación Americana del Corazón Insta a Comunidades a Implementar Planes CERP que Salvan Vidas
Sotera Health Announces Third-Quarter 2025 Earnings Release Date
Supernus Pharmaceuticals to Announce Third Quarter 2025 Financial Results and Host Conference Call on November 4, 2025
Jushi Holdings Inc. to Report Third Quarter 2025 Financial Results on November 4, 2025
STERIS to Host a Conference Call for Fiscal 2026 Second Quarter Results on November 6, 2025
Aveanna Announces Launch of Secondary Offering of Common Stock
Teva und Prestige Biopharma schließen Lizenzvereinbarung für die Vermarktung von Tuznue® in Europa
Teva et Prestige Biopharma concluent un accord de licence pour la commercialisation de Tuznue® en Europe
Aveanna Healthcare Holdings Announces Preliminary Third Quarter Financial Results
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
Ceribell to Report Third Quarter 2025 Financial Results on November 4, 2025
Intuitive Announces Third Quarter Earnings
Eagle Pharmaceuticals Announces Results of 2025 Annual Meeting of Stockholders
Inotiv, Inc. to Participate in Three Investor Conferences in November 2025
NurExone Invited Presenter at Precision EV Forum in Cambridge, UK
RAPT Therapeutics Announces Proposed Public Offering of Common Stock

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions